Bangalore, India, 560085
Dapagliflozin 5mg + Metformin 500mg ER is a combination oral medication designed for effective management of type 2 diabetes mellitus. Dapagliflozin, a sodium-glucose co-transporter-2 (SGLT2) inhibitor, helps reduce blood sugar by promoting the excretion of glucose through urine. Metformin (extended release) decreases hepatic glucose production and improves insulin sensitivity, providing a dual approach to glycemic control. The extended-release formulation ensures a sustained effect, improves patient compliance, and minimizes gastrointestinal side effects commonly associated with standard metformin tablets. This combination is suitable for adults who require enhanced blood sugar control alongside lifestyle modifications, such as diet and exercise, to manage type 2 diabetes. Regular monitoring of blood glucose and adherence to prescribed dosage are essential for optimal results.